Evidence suggests that the interleukin (IL)‐36 pathway plays a key role in the pathology of GPP, and several studies have indicated that Asian patients with GPP have high rates (46.8%–81.8%) of mutations in IL36RN, the gene encoding the IL‐36 receptor antagonist. This evidence concerns the gene IL36RN and psoriasis 14, pustular.